AI-generated summary
In a randomized placebo-controlled trial of 110 adults with subthreshold depression, the authors report that eight weeks of morning bright light therapy was associated with reduced depressive symptoms and changes in glymphatic markers, brain activity and inflammatory cytokines compared with placebo. The authors describe the findings as correlational and suggest a possible link between glymphatic function and symptom improvement.
- Participants
- 110
- Who or what was studied
- Adults with subthreshold depression
- Limits stated in the abstract
- The abstract does not describe the study's limits; findings are described as correlational and the mechanism is not established.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Depression, Bright light therapy, Placebo-controlled, Primary outcome, Inflammation, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.